JENBURKT PHARMACEUTICALS
Back to Balance Sheet
|
JENBURKT PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹16 Cr | ₹16 Cr | ₹21 Cr | ₹18 Cr | ₹20 Cr |
What is the latest Total Current Liabilities ratio of JENBURKT PHARMACEUTICALS ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹16 Cr |
Mar2023 | ₹16 Cr |
Mar2022 | ₹21 Cr |
Mar2021 | ₹18 Cr |
Mar2020 | ₹20 Cr |
How is Total Current Liabilities of JENBURKT PHARMACEUTICALS Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹16 Cr | 3.91 | |
Mar2023 | ₹16 Cr | -25.93 | |
Mar2022 | ₹21 Cr | 18.27 | |
Mar2021 | ₹18 Cr | -9.52 | |
Mar2020 | ₹20 Cr | - |
Compare Total Current Liabilities of peers of JENBURKT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JENBURKT PHARMACEUTICALS | ₹465.0 Cr | -4.7% | -16% | 38.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,827.0 Cr | -3.1% | -3.9% | 12.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,931.0 Cr | -2.9% | -0.8% | 62.5% | Stock Analytics | |
CIPLA | ₹117,322.0 Cr | 1.1% | 0.3% | 1.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,116.0 Cr | -1.3% | -9.4% | -0.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹94,752.0 Cr | -3.7% | -5.9% | 19.7% | Stock Analytics |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JENBURKT PHARMACEUTICALS | -4.7% |
-16% |
38.3% |
SENSEX | -2.9% |
-0.1% |
6.8% |
You may also like the below Video Courses